Piperazine derivatives as iron chelators: a potential application in neurobiology. (Q52147545)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Piperazine derivatives as iron chelators: a potential application in neurobiology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

S Abdelsayed

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

N T Ha Duong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

C Bureau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J M El Hage Chahine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

N Serradji

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

1 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

1043-1061

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26502356%20AND%20SRC:MED&resulttype=core&format=json

Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Iron transport and storage proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Lipid peroxidation as cause of nigral cell death in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Increased nigral iron content in postmortem parkinsonian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Synthesis and iron sequestration equilibria of novel exocyclic 3-hydroxy-2-pyridinone donor group siderophore mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Chemistry and biology of siderophores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Iron: Effect of Overload and Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Iron transport-mediated drug delivery: practical syntheses and in vitro antibacterial studies of tris-catecholate siderophore-aminopenicillin conjugates reveals selectively potent antipseudomonal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

The Haber-Weiss cycle--70 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Kinetics, thermodynamics, and modeling of complex formation between calix[4]biscrowns and cesium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Norbadione A: Kinetics and Thermodynamics of Cesium Uptake in Aqueous and Alcoholic Media

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Chelating agents for the treatment of systemic iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Complexation of labile metal ions and effect on toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

The novel mitochondrial iron chelator 5-((methylamino)methyl)-8-hydroxyquinoline protects against mitochondrial-induced oxidative damage and neuronal death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Siderophores: Structure and Function of Microbial Iron Transport Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

An evolving role of piperazine moieties in drug design and discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Microbial siderophores: a mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Structure, function and binding selectivity and stereoselectivity of siderophore-iron outer membrane transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Missing pieces in the Parkinson's disease puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Molecular and clinical prodrome of Parkinson disease: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Kinetics and thermodynamics of complex formation with iron of a new series of dicatecholspermidine siderophore-like ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Designing prodrugs for the treatment of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Neuroprotective effects of ginkgetin against neuroinjury in Parkinson's disease model induced by MPTP via chelating iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Microbial siderophore-mediated transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X

Design of iron chelators with therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-015-9889-X